133 related articles for article (PubMed ID: 31014509)
1. Role of epigenetic mechanisms in cisplatin-induced toxicity.
Quintanilha JCF; Saavedra KF; Visacri MB; Moriel P; Salazar LA
Crit Rev Oncol Hematol; 2019 May; 137():131-142. PubMed ID: 31014509
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
Najjar TA; Saad SY
Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review.
de Godoy Torso N; Pereira JKN; Visacri MB; Vasconcelos PENS; Loren P; Saavedra K; Saavedra N; Salazar LA; Moriel P
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884570
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Regulation in Kidney Toxicity: Insights From Cisplatin Nephrotoxicity.
Xiang X; Guo C; Tang C; Cai J; Dong Z
Semin Nephrol; 2019 Mar; 39(2):152-158. PubMed ID: 30827338
[TBL] [Abstract][Full Text] [Related]
6. [Can cisplatin renal toxicity be prevented?].
Brillet G; Deray G; Bunker D; Ben Hmida M; Baumelou A; Jacobs C
Nephrologie; 1991; 12(3):143-6. PubMed ID: 1922654
[TBL] [Abstract][Full Text] [Related]
7. Aging increases the susceptibility of cisplatin-induced nephrotoxicity.
Wen J; Zeng M; Shu Y; Guo D; Sun Y; Guo Z; Wang Y; Liu Z; Zhou H; Zhang W
Age (Dordr); 2015 Dec; 37(6):112. PubMed ID: 26534724
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Cisplatin-Induced Nephrotoxicity: A Multicenter Retrospective Study.
Miyoshi T; Uoi M; Omura F; Tsumagari K; Maesaki S; Yokota C
Oncology; 2021; 99(2):105-113. PubMed ID: 32966986
[TBL] [Abstract][Full Text] [Related]
9. [Renal protection with amifostine during intraoperative peritoneal chemohyperthermia (IPCH) with cisplatin (CDDP) for peritoneal carcinosis. Phase 1 study].
Vaira M; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Med; 2001 Aug; 92(4):207-11. PubMed ID: 11535965
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through
Vera O; Jimenez J; Pernia O; Rodriguez-Antolin C; Rodriguez C; Sanchez Cabo F; Soto J; Rosas R; Lopez-Magallon S; Esteban Rodriguez I; Dopazo A; Rojo F; Belda C; Alvarez R; Valentin J; Benitez J; Perona R; De Castro J; Ibanez de Caceres I
Theranostics; 2017; 7(17):4118-4134. PubMed ID: 29158814
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of proton pump inhibitors ameliorates nephrotoxicity in patients receiving chemotherapy with cisplatin and fluorouracil: a retrospective cohort study.
Ikemura K; Oshima K; Enokiya T; Okamoto A; Oda H; Mizuno T; Ishinaga H; Muraki Y; Iwamoto T; Takeuchi K; Katayama N; Okuda M
Cancer Chemother Pharmacol; 2017 May; 79(5):943-949. PubMed ID: 28364288
[TBL] [Abstract][Full Text] [Related]
12. Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats.
Li CY; Song HT; Wang XX; Wan YY; Ding XS; Liu SJ; Dai GL; Liu YH; Ju WZ
Sci Rep; 2017 Jun; 7(1):3619. PubMed ID: 28620200
[TBL] [Abstract][Full Text] [Related]
13. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy].
Shibuya M; Hirosawa A; Niitani H
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664
[TBL] [Abstract][Full Text] [Related]
14. The aqueous extract of cinnamon bark ameliorated cisplatin-induced cytotoxicity in vero cells without compromising the anticancer efficiency of cisplatin.
ElKady AI; Ramadan WS
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):363-71. PubMed ID: 27465514
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin: process and future.
Stathopoulos GP
J BUON; 2013; 18(3):564-9. PubMed ID: 24065465
[TBL] [Abstract][Full Text] [Related]
16. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity.
Chirino YI; Pedraza-Chaverri J
Exp Toxicol Pathol; 2009 May; 61(3):223-42. PubMed ID: 18986801
[TBL] [Abstract][Full Text] [Related]
17. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
[TBL] [Abstract][Full Text] [Related]
19. Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.
Abdel-Daim MM; El-Sayed YS; Eldaim MA; Ibrahim A
Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):301-309. PubMed ID: 27975300
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression.
Sogawa N; Hirai K; Sogawa C; Ohyama K; Miyazaki I; Tsukamoto G; Asanuma M; Sasaki A; Kitayama S
Life Sci; 2013 Apr; 92(12):727-32. PubMed ID: 23399700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
